The Lok Sabha will take up the contentious Waqf (Amendment) Bill for discussion and passage today. NDA backed parties ...

Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

Alembic Pharmaceuticals has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDAPantoprazole Sodium for Injection, 40 mg/vial ...

Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data ...

Bill, 2024, is set to be presented in Parliament today. Both the Bharatiya Janata Party (BJP) and Congress have instructed ...

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application ...

The Congress party issued the three-line whip after the government made it clear that the contentious Waqf (Amendment) Bill ...

Congress MP K Suresh on Wednesday said that the INDIA bloc is against the Waqf Amendment Bill and will oppose it in the parliament. "The entire opposition is against this bill. Our members in the ...

Union Parliamentary Affairs Minister Kiren Rijiju moved the Waqf Amendment Bill, 2024 in the Parliament on Wednesday ...

The government says it tightened citizenship rules because of a deluge of applications from the descendants of emigrants who only coveted an Italian passport. By Patricia Mazzei The eruption ...